expression, at least in vitro, whereas lipopolysaccharide (LPS) has recently been shown Secretory leukoprotease inhibitor (SLPI) is a low molecular weight serine protease to induce SLPI production by macrophages which may antagonise LPS induced signalling inhibitor found on various mucosal surfaces and has been ascribed an important and secretion.
Figure 1 Schematic representation of the possible modes of antifungal activity of secretory leukoprotease inhibitor (SLPI) against Aspergillus fumigatus (Af) in the mucosal defence of the airways. Impaction of A fumigatus spores on the mucosal surface may result in local germination of fungal spores and growth of A fumigatus hyphae. Release of fungal proteases may result in epithelial cell detachment and production of pro-inflammatory cytokines by these cells
equine neutrophils (eNAP-2) and its sequence airborne (metabolically quiescent) type of A fumigatus conidia were totally resistant to the homology to SLPI, Hiemstra and coworkers investigated the in vitro antibacterial activity of action of rSLPI. Candida albicans yeast cells were also killed in a dose dependent fashion rSLPI against Escherichia coli (Gram negative) and Staphylococcus aureus (Gram positive). 7 A by rSLPI (50% fungicidal activity at 10.0 M) and, in addition, the growth rate of a C albicans dose dependent bactericidal activity of rSLPI towards both organisms was found but, with E inoculum in culture medium was inhibited significantly. 9 As with the antibacterial activity coli as a target organism, the activity of rSLPI was found to be lower than the cationic anti-described by Hiemstra, 7 the antifungal activity was mainly localised in the amino terminal microbial polypeptides, lysozyme and defensins, on a molar basis. The mechanism of the domain while the concentration at which rSLPI displays bactericidal and antifungal activities in SLPI mediated bactericidal activity is largely unknown but may include binding of the pro-vitro (>2 M) appears to be relevant to the in vivo situation in the lung. The bactericidal and tease inhibitor to bacterial mRNA and DNA. 8 Hiemstra, however, proposed that this mech-antifungal activity may be related to the cationic nature of SLPI 7 9 as was previously described anism pertained to bacteria endogenously producing rSLPI but may not fully explain the for other cationic peptides such as defensins.
In other studies 10 we also found a partial observed antibacterial activity of rSLPI added exogenously to these cells. 7 The SLPI molecule inhibition of fungal protease activity by rSLPI (fig 1) , a putative virulence factor of A fumicomprises two largely identical domains; the carboxy terminal domain contains the protease gatus. Following the inhibition of fungal protease activity, rSLPI also inhibited the induction of inhibitory site whereas the function of the amino terminal domain is largely unknown. the pro-inflammatory cytokine response in cultured human airway epithelial cell lines Remarkably, the bactericidal activity was found to be located primarily in the amino terminal (fig 1) . 10 domain of rSLPI.
7
Therapeutic potential rSLPI has proved to be active in physiological   We have recently completed studies on the concentrations against some pathogenic fungi and bacteria in vitro and HIV. It is available antifungal activity of rSLPI against human isolates of the pathogenic fungi Aspergillus fumigatus for therapeutic use and is, in fact, being considered for the treatment of inflammatory lung and Candida albicans 9 and found a statistically significant and dose dependent killing of A diseases. 1 The potential clinical importance of SLPI in limiting airway inflammation was fumigatus conidia (50% fungicidal activity at 5.8 M) provided that the conidia were pre-shown by McElvaney and Crystal 11 in the early 1990s in patients with cystic fibrosis. rSLPI in incubated in a watery solution to induce metabolic activity of the fungal cells (fig 1) . The a dose of 100mg was administered to these group.bmj.com on October 20, 2017 -Published by http://thorax.bmj.com/ Downloaded from patients twice daily for one week and resulted and killing the organisms involved, rSLPI may prove to be a useful agent in supporting the in a significant reduction in both elastase acnative host defence, supplying the patient with tivity and IL-8 levels in epithelial lining fluid.
the necessary tools to combat pulmonary inProbably as a result of decreased IL-8 levels, a fection. marked reduction in neutrophil number in the epithelial lining fluid was also found, thereby 
